{"id":419500,"date":"2019-08-14T11:12:01","date_gmt":"2019-08-14T11:12:01","guid":{"rendered":"http:\/\/www.abnewswire.com\/pressreleases\/?p=419500"},"modified":"2019-08-14T11:12:01","modified_gmt":"2019-08-14T11:12:01","slug":"antacids-market-analysis-on-the-basis-of-dosage-form-distribution-channel-region-and-forecast-till-2025-grand-view-research-inc","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/antacids-market-analysis-on-the-basis-of-dosage-form-distribution-channel-region-and-forecast-till-2025-grand-view-research-inc_419500.html","title":{"rendered":"Antacids Market Analysis On The Basis Of Dosage Form, Distribution Channel, Region And Forecast Till 2025: Grand View Research Inc."},"content":{"rendered":"
\"Antacids<\/a><\/p>\n
\n
Grand View Research, Inc. – Market Research And Consulting.<\/div>\n<\/div>\n<\/div>\n
According to report published by Grand View Research, The global antacids market size was valued at USD 5.83 billion in 2017 and is projected to expand at a CAGR of 3.9% over the forecast period.<\/div>\n

The global antacid market<\/a> size is expected to reach USD 7.91 billion by 2025, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 3.9% over the forecast period. The trend of self-medication for occasional heartburn is one of the major factors driving the market.<\/p>\n

Growing geriatric population is expected to positively impact the overall market for antacid. According to the United Nations Department of Economic And Social Affairs (DESA), the global elderly population (60 years and above), was around 962 million in 2017. This number is expected to grow at the fastest rate in Latin America with 71% increase in population aged 60 and over, followed by Asia with 66%, Africa with 64%, North America with 41%, and Europe with 23%.<\/p>\n

Key players operating in antacid market focus on product enhancement to cater to patient requirements, such as changing the dosage form into chewable tablets, powder, and jelly. Also, these players are involved in collaborations and acquisitions to expand their market presence. For instance, in 2017, Pfizer, Inc. entered into a strategic agreement with AstraZeneca to acquire one of the antacid brands, Neksium for a value of INR 75 crores in India to boost its product portfolio.<\/p>\n

The easy availability of antacids over-the-counter offer growth opportunities for the sales of overall market. Some of the key players areGlaxoSmithKline plc; AstraZeneca; Pfizer, Inc.; Sun Pharmaceuticals Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited.<\/p>\n

\"U.S.<\/p>\n

Request a sample Copy of the Antacids Market Research Report @<\/strong> https:\/\/www.grandviewresearch.com\/industry-analysis\/antacids-market\/request\/rs1<\/a><\/p>\n

Key Takeways Of The Report :<\/strong><\/p>\n